Climb Bio (CLYM) Enterprise Value (2020 - 2026)
Climb Bio (CLYM) posted Enterprise Value of -$109.6 million for Q1 2026, down 8.39% on a QoQ basis from -$101.1 million in Q4 2025, and down 11.73% year-over-year from -$124.1 million in Q1 2025.
Climb Bio (CLYM) Enterprise Value (2020 - 2026) Analysis & Trends
Climb Bio's Enterprise Value history runs 7 years deep, the most recent figure standing at -$109.6 million for Q1 2026.
- Quarterly Enterprise Value fell 11.73% year-over-year to -$109.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$109.6 million (down 11.73% YoY) and the FY2025 annual result came in at -$101.1 million, up 33.02% from the prior year.
- Enterprise Value was -$109.6 million for Q1 2026 at Climb Bio, down from -$101.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$84.7 million in Q2 2025 and bottomed at -$261.7 million in Q3 2024.
- A 5-year average of -$130.8 million and a median of -$109.6 million in 2026 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 143.6% — and 2025, when it jumped 66.79%.
- Climb Bio's Enterprise Value stood at -$123.6 million in 2022, then climbed by 5.66% to -$116.6 million in 2023, then retreated by 29.47% to -$150.9 million in 2024, then jumped by 33.02% to -$101.1 million in 2025, then declined by 8.39% to -$109.6 million in 2026.
- Business Quant data shows CLYM's Enterprise Value at -$109.6 million in Q1 2026, -$101.1 million in Q4 2025, and -$86.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -109.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.56 Mn |
| Dec 31, 2025 | -101.08 Mn |
| Sep 30, 2025 | -86.90 Mn |
| Jun 30, 2025 | -84.70 Mn |
| Mar 31, 2025 | -98.06 Mn |
| Dec 31, 2024 | -150.92 Mn |
| Sep 30, 2024 | -261.70 Mn |
| Jun 30, 2024 | -218.12 Mn |
| Mar 31, 2024 | -103.24 Mn |
| Dec 31, 2023 | -116.57 Mn |
| Sep 30, 2023 | -107.43 Mn |
| Jun 30, 2023 | -102.63 Mn |
| Mar 31, 2023 | -109.37 Mn |
| Dec 31, 2022 | -123.57 Mn |
| Sep 30, 2022 | -203.06 Mn |
| Jun 30, 2022 | -122.95 Mn |
| Mar 31, 2022 | -123.94 Mn |
| Dec 31, 2021 | -136.48 Mn |
| Sep 30, 2021 | -228.43 Mn |
| Jun 30, 2021 | -99.48 Mn |